Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Scientists and clinician scientists at Princess Margaret Cancer Centre will lead four of five large-scale research initiatives launched today by The Ontario Institute for Cancer Research (OICR).
Ontario Minister of Research, Innovation and Science, Reza Moridi announced a $24-million investment over two years for the OICR's Translational Research Initiatives (TRIs). The TRIs will bring together world-leading scientists to tackle some of the most difficult to treat cancers and test innovative solutions to some of the most serious challenges in cancer.
"This kind of support for collaboration and translational research helps ensure that we can continue to bring cutting-edge science to the clinic to improve care for patients," said Dr. Peter Pisters, UHN President & CEO.
Six clinician scientists at the Princess Margaret will lead the following TRIs:
"Leading four of the five research initiatives is a testament to the extraordinary talent of our researchers and clinicians who are continuing to expand our understanding of cancer, and through collaboration, developing and evaluating new approaches to therapy," says Dr. Brad Wouters, UHN's Executive Vice-President, Science & Research.
To learn more about the initiatives, read the full news release.